Case number 1:19-cv-00264
Genzyme Corp. et al v. Zenara Pharma Private Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2020 | 1 | Complaint (21) |
| Dec 2, 2019 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per Dismissal Order (D.I. 75) in LEAD CASE NO. 18-1795-CFC. (fms) |
| Apr 30, 2019 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-01795-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 18-1795-CFC ONLY. (nmf) |
| Apr 30, 2019 | 15 | Order (2) Docket Text: CONSOLIDATION AND SCHEDULING ORDER, Civ. No. 19-264-CFC is consolidated with for all purposes with the cases consolidated in in Civ. No. 18-1795-CFC. ALL FUTURE FILINGS SHALL BE MADE IN 18-1795-CFC ONLY. The parties shall be bound by the Scheduling Order entered on February 4, 2019 in C.A. 18-1795-CFC subject to the modifications outlined in this order. Signed by Judge Colm F. Connolly on 4/30/2019. Associated Cases: 1:18-cv-01795-CFC, 1:19-cv-00264-CFC(nmf) |
| Apr 26, 2019 | 13 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Rule 26(a)(1) Initial Disclosures; (2) Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery; and (3) Core Technical Document Production Pursuant to Paragraph 4 of the Default Standand filed by Zenara Pharma Private Limited.(Metzler, Sara) |
| Apr 26, 2019 | 14 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Plaintiffs' Disclosures Pursuant to Delaware Default Paragraph 4(a), 2) Plaintiffs' Disclosures Pursuant to Delaware Default Standard Paragraph 3 and 3) Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Genzyme Corp., Regents of the University of Michigan.(Fahnestock, Derek) |
| Apr 25, 2019 | 12 | Proposed Order (2) |
| Apr 25, 2019 | 12 | Cover Letter (1) |
| Apr 25, 2019 | 12 | Main Document (2) Docket Text: PROPOSED ORDER /Proposed Consolidation and Scheduling Order by Genzyme Corp., Regents of the University of Michigan. (Attachments: # (1) Cover Letter)(Fahnestock, Derek) |
| Mar 25, 2019 | 11 | Order (1) Docket Text: ORDER, the above-captioned case having been recently joined and ready for scheduling pursuant to Fed. R. Civ. P. 16 and as this case is listed as related to earlier filed cases that are currently proceeding on an agreed upon schedule entered by the Court; IT IS ORDERED that, on or before April 26, 2019, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed.ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 4/26/2019.) Signed by Judge Colm F. Connolly on 3/25/2019. (nmf) |
| Mar 12, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Christopher A. Pinahs for Zenara Pharma Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Mar 6, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] MOTION for Pro Hac Vice Appearance of Attorney Christopher A. Pinahs filed by Zenara Pharma Private Limited. Signed by Judge Colm F. Connolly on 3/6/2019. (fms) |
| Mar 4, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Mar 4, 2019 | 10 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Christopher A. Pinahs - filed by Zenara Pharma Private Limited. (Metzler, Sara) |
| Feb 28, 2019 | N/A | SO ORDERED (0) |
| Feb 28, 2019 | 8 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Biophore India Pharmaceuticals Pvt Ltd. for Zenara Pharma Private Limited filed by Zenara Pharma Private Limited. (Cottrell, Frederick) |
| Feb 28, 2019 | 9 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jake M. Holdreith of Robins Kaplan LLP - filed by Zenara Pharma Private Limited. (Metzler, Sara) |
| Feb 27, 2019 | 7 | Answer to Complaint (24) Docket Text: ANSWER to [1] Complaint, and Affirmative Defenses by Zenara Pharma Private Limited.(Cottrell, Frederick) |
| Feb 13, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Feb 12, 2019 | 6 | Declaration (9) Docket Text: DECLARATION of Mailing (as to service on Zenara Pharma Private Limited) by Genzyme Corp., Regents of the University of Michigan. (Fahnestock, Derek) |
| Feb 8, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Zenara Pharma Private Limited on 2/8/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Feb 7, 2019 | 1 | Exhibit A-D (112) |
| Feb 7, 2019 | 1 | Civil Cover Sheet (1) |
| Feb 7, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Feb 7, 2019 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/2/2019. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 2/19/2022. (nmg) |
| Feb 7, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,196,205 B2; 6,916,802 B2; 7,253,185 B2; 7,615,573 B2. (nmg) |
| Feb 7, 2019 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aventis Inc., Other Affiliate Sanofi, Other Affiliate Sanofi-Aventis Amerique du Nord for Genzyme Corp. filed by Genzyme Corp.. (nmg) |
| Feb 7, 2019 | 1 | Main Document (21) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Zenara Pharma Private Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2565227.) - filed by Regents of the University of Michigan, Genzyme Corp.. (Attachments: # (1) Exhibit A-D, # (2) Civil Cover Sheet)(nmg) |
| Feb 7, 2019 | 1 | Complaint* (1) |
